Jiazhong (Jason) Luo

Replay: Wearables Webinar Series, Part 3: Product Liability And IP Strategies For Wearables (Video)

Federal Circuit Affirms Delisting Patents Claiming Device Components Of Drug Product Without Active Ingredient

Federal Circuit Affirms Delisting Patents Claiming Device Components Of Drug Product Without Active Ingredient

FTC Cracks Down On Allegedly Deceptive Artificial Intelligence Schemes

Federal Circuit Revives Induced Infringement Suit Against Generic Pharma When Its Skinny Label Is Skinny Enough

District Court Of Delaware Rules For Generic Pharma's Use Of Skinny Label, But Permits Induced Infringement Suit To Proceed Against Insurer